You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 3.2% | 3.7% |
| Div Cover | 2.8 | 2.0 |
| Op Mrgn | 23.4% | 37.3% |
| ROCE | 117.7% |
| Latest | Forecast | |
|---|---|---|
| P/E | 11.0 | 1,471.7 |
| PEG | 0.1 | -3.6 |
| Price / Revenue | 4.4 | 4.3 |
| Price / Book value | 3.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -0.5% | -3.2% |
| PBT | 47.3% | n/a |
| EPS | 202.5% | -6.1% |
| DPS | 6.7% | -1.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | 49,605.00 | 12,240.00 | $1.43 | 21.8 | -0.6 | -36% | $1.04 | 3.3% |
| 2015-12-31 | 48,851.00 | 8,965.00 | $1.13 | 28.6 | -1.4 | -21% | $1.12 | 3.5% |
| 2016-12-31 | 52,824.00 | 8,351.00 | $1.18 | 27.5 | 6.2 | 4% | $1.20 | 3.7% |
| 2017-12-31 | 52,546.00 | 12,305.00 | $3.57 | 10.1 | 0.1 | 203% | $1.28 | 3.5% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 53,647.00 | 21,295.01 | $3.00 | 1,415.7 | -88.7 | -16% | $1.36 | 3.2% |
| 2019-12-31 | 53,247.41 | 19,882.64 | $2.89 | 1,471.7 | -392.8 | -4% | $1.44 | 3.4% |
| 2020-12-31 | 54,036.24 | 20,617.57 | $3.05 | 1,420.4 | 249.4 | 6% | $1.51 | 3.6% |
| GSK gets US green light for two-drug HIV treatment Sharecast News | 09 Apr |
|---|---|
| Pfizer buys 15% stake in French gene therapy company Vivet Sharecast News | 20 Mar |
| Pharma firms to testify in Congress over drug pricing Sharecast News | 26 Feb |